Literature DB >> 9264681

[The validity of 6 indirect methods for assessing compliance with pharmacological treatment in dyslipidemias].

F Piñeiro1, V Gil, M Donis, D Orozco, M T Torres, J Merino.   

Abstract

OBJECTIVE: To validate six indirect methods of identifying patients who do not comply with their treatment with hypolipaemiant drugs.
DESIGN: A prospective study.
SETTING: Primary care centres in the province of Alicante. PATIENTS: 107 lipaemic patients, on the lists of 5 General Medical practices and on drugs treatment.
MEASUREMENTS AND MAIN RESULTS: The most accurate way to assess compliance was the surprise counting of pills in patients' homes. Patients who had between 80 and 110% compliance were defined as compliant. The six indirect methods validated were: Communication of self-compliance (CS), Attendance at appointments (AA), Doctor's judgment (DJ), Information about the illness (II), the Morisky-Green test (MG) and the grade of control (GC). AA, DJ and CS were the methods with highest specificity (91.2%-89.5%). GC and II were the most sensitive (88%-82%). GC obtained the greatest negative predictive value (77.7%), and DJ the greatest positive predictive value (73.6%). The concordance index (kappa) ranged from 0.23 for GC and -0.002 for II.
CONCLUSIONS: GC, DJ and CS are the methods with the best validity indicators and concordance. They could, therefore, be used together in clinical practice to identify patients not complying with their hypolipemiant treatment.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9264681

Source DB:  PubMed          Journal:  Aten Primaria        ISSN: 0212-6567            Impact factor:   1.137


  8 in total

Review 1.  [Treatment compliance: what do we know about Spain?].

Authors:  A Rigueira García
Journal:  Aten Primaria       Date:  2001-05-15       Impact factor: 1.137

2.  Adherence of rheumatoid arthritis patients to biologic disease-modifying antirheumatic drugs: a cross-sectional study.

Authors:  Natalia Mena-Vazquez; Sara Manrique-Arija; Lucía Yunquera-Romero; Inmaculada Ureña-Garnica; Marta Rojas-Gimenez; Carla Domic; Francisco Gabriel Jimenez-Nuñez; Antonio Fernandez-Nebro
Journal:  Rheumatol Int       Date:  2017-06-19       Impact factor: 2.631

3.  [Effectiveness of self-measurement of blood pressure in patients with hypertension: the Dioampa study].

Authors:  A Dalfó i Baqué; R Capillas Peréz; M Guarch Rocarias; M Figueras Sabater; A Ylla-Català Passola; M Balañá Vilanova; Jm Vidal Taboada; A Cobos Carbó
Journal:  Aten Primaria       Date:  2005-03-31       Impact factor: 1.137

Review 4.  Interventions to improve adherence to lipid lowering medication.

Authors:  A Schedlbauer; K Schroeder; T J Peters; T Fahey
Journal:  Cochrane Database Syst Rev       Date:  2004-10-18

5.  Determinant factors of osteoporosis patients' reported therapeutic adherence to calcium and/or vitamin D supplements: a cross-sectional, observational study of postmenopausal women.

Authors:  José Sanfelix-Genovés; Vicente F Gil-Guillén; Domingo Orozco-Beltran; Vicente Giner-Ruiz; Salvador Pertusa-Martínez; Begoña Reig-Moya; Concepción Carratalá
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

6.  Is it possible to diagnose the therapeutic adherence of patients with COPD in clinical practice? A cohort study.

Authors:  Pilar Barnestein-Fonseca; José Leiva-Fernández; Francisca Vidal-España; Antonio García-Ruiz; Daniel Prados-Torres; Francisca Leiva-Fernández
Journal:  BMC Pulm Med       Date:  2011-01-24       Impact factor: 3.317

7.  Factors Associated with Non-Adherence to Drugs in Patients with Chronic Diseases Who Go to Pharmacies in Spain.

Authors:  Carmen Valdés Y Llorca; Ernesto Cortés Castell; José Manuel Ribera Casado; Pilar de Lucas Ramos; José Luis Casteig Ayestarán; Amaia Casteig Blanco; Vicente Francisco Gil Guillén; Mercedes Rizo Baeza
Journal:  Int J Environ Res Public Health       Date:  2021-04-19       Impact factor: 3.390

8.  Patients' Views on the Design of DiabeText, a New mHealth Intervention to Improve Adherence to Oral Antidiabetes Medication in Spain: A Qualitative Study.

Authors:  Rocío Zamanillo-Campos; Maria Jesús Serrano-Ripoll; Joana Maria Taltavull-Aparicio; Elena Gervilla-García; Joana Ripoll; Maria Antonia Fiol-deRoque; Anne-Marie Boylan; Ignacio Ricci-Cabello
Journal:  Int J Environ Res Public Health       Date:  2022-02-08       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.